Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1056 participants.

Also called NCT01349777

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,056 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01349777
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01349777. Randomized; no masking; primary purpose prevention. Start 2010-03-15 (actual); primary completion 2017-03-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
Intervention (Drug)
Pregrel®
Intervention (Drug)
Plavix®
Lead sponsor
Seung-Jung Park (class: other)
Collaborator
CardioVascular Research Foundation, Korea (class: other)

Record details

Record id
cardio:ct-nct01349777
Content hash
da87488f964568d29b4f9963cbcd3a3b547c8e69d057db64b93b47d98661d773